Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways.
about
Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender DifferencesPromoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant gliomaThe ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells.
P2860
Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Quetiapine inhibits osteoclast ...... and NF-κB signaling pathways.
@en
type
label
Quetiapine inhibits osteoclast ...... and NF-κB signaling pathways.
@en
prefLabel
Quetiapine inhibits osteoclast ...... and NF-κB signaling pathways.
@en
P2093
P2860
P1476
Quetiapine inhibits osteoclast ...... and NF-κB signaling pathways.
@en
P2093
Hongkai Wang
Tongwei Chu
Weiwei Shen
Ying Zhang
Yunyun Zhuo
P2860
P2888
P304
P356
10.1007/S10549-015-3290-X
P407
P577
2015-02-10T00:00:00Z
P5875
P6179
1023275910